Semaglutide-Induced Weight Loss: Consequences for Muscle Mass and Functional Outcomes
Introduction: Semaglutide (Ozempic) is a long-acting GLP-1 receptor agonist used in the treatment of type 2 diabetes and obesity. Its potent effects on appetite suppression, delayed gastric emptying, and weight reduction are well documented. Increasing scientific attention has focused on its potent...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Kazimierz Wielki University
2026-02-01
|
| Seri Bilgileri: | Journal of Education, Health and Sport |
| Konular: | |
| Online Erişim: | https://apcz.umk.pl/JEHS/article/view/68182 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|